Glytec Achieves Gold Stevie® Award for Healthcare Technology
Glytec Wins Gold Stevie® Award for Healthcare Technology Excellence
Glytec has been recognized as a leader in healthcare technology after being awarded the Gold Stevie® Award as the Healthcare Technology Company of the Year. This accolade highlights Glytec's innovative advancements in AI-powered solutions, dedicated to managing diabetes in hospitals and health systems.
Recognizing Technological Achievements Across Industries
The Stevie Awards for Technology Excellence celebrate notable contributions from individuals and organizations that are effectively and creatively shaping the future of technology across various sectors. Glytec's achievement serves as a testament to its dedication and impactful work in healthcare.
Excellence in Inpatient Diabetes Management
This year, Glytec earned its Gold Stevie® Award within the competitive Healthcare Technology Solution category. Its flagship product, the Glucommander® software platform, stands out as the first FDA-cleared cloud-based solution designed for personalized insulin dosing in hospital settings. This innovative platform is pivotal in enhancing patient outcomes and streamlining clinical workflows, addressing critical diabetes management within hospitals.
Navigating New Healthcare Standards
As hospitals prepare for forthcoming glycemic management measures mandated by the Centers for Medicare & Medicaid Services (CMS) in 2026, Glytec is positioned strategically with its proven technologies. Glytec's Glucommander® is already utilized by over 400 hospitals nationwide, which enhances its capability to help health systems meet new compliance standards.
Proven Impact and Medical Innovations
Supported by extensive clinical research, the Glucommander® platform has demonstrated impressive results, including reductions in hospital stay lengths and improved patient care, underscored by a wealth of data—over 50 billion data points amassed over nearly two decades of operation.
CEO Patrick Cua's Insights
Patrick Cua, CEO at Glytec, commented on this honor, stating, "This recognition further validates almost 20 years of experience in managing complex diabetes workflows through our technology platform. We are proud of the positive impact we have on hospitals and patients alike.”
Judging Process and Competitor Landscape
This year, the judging panel consisted of more than 160 professionals from various industries who carefully evaluated nominations from organizations worldwide. Glytec stood out among 1,500 entries, solidifying its status as an innovative leader in healthcare technology.
Looking Ahead
Glytec aims to further enhance its technologies and expand its reach in helping healthcare providers improve diabetes management. Its commitment to innovation and patient safety remains unwavering as it navigates the evolving technological landscape in healthcare.
The Importance of the Stevie Awards
The Stevie Awards have long honored outstanding contributions across all areas of business and technology, offering recognition for performance and achievements that shape industries worldwide. The 2025 honorees demonstrate remarkable advancements that serve the community's needs in crucial sectors.
About Glytec
Glytec's leading technology platform is used by over 400 hospitals, enabling seamless diabetes management and insulin dosing that improves patient care and operational efficiency. The company is dedicated to harmonizing clinical decision support and patient monitoring through its Glucommander® software, optimizing healthcare outcomes from inpatient care to home.
Frequently Asked Questions
What award did Glytec win?
Glytec won the Gold Stevie® Award as the Healthcare Technology Company of the Year.
What is Glucommander®?
Glucommander® is Glytec's FDA-cleared cloud-based platform for personalized insulin dosing in hospital settings, designed to improve diabetes management.
How many hospitals use Glytec's technology?
More than 400 hospitals across the nation utilize Glytec's Glucommander® platform for diabetes management solutions.
What recent changes will Glytec assist hospitals with?
Glytec helps hospitals comply with new glycemic management measures set to take effect in 2026.
Who is the CEO of Glytec?
Patrick Cua is the CEO of Glytec and has remarked on the company's ongoing commitment to innovation in diabetes management.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.